FL
REGN icon

Fort LP’s Regeneron Pharmaceuticals REGN Stock Holding History

Fort LP’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$270K Sell
257
-31
-11% -$34.5K 0.68% 61
2024
Q2 		$303K Buy
288
+3
+1% +$2.91K 0.77% 29
2024
Q1 		$274K Sell
285
-38
-12% -$36.1K 0.69% 53
2023
Q4 		$284K Sell
323
-25
-7% -$20.6K 0.7% 43
2023
Q3 		$286K Sell
348
-20
-5% -$15.7K 0.79% 36
2023
Q2 		$264K Sell
368
-49
-12% -$37.8K 0.7% 76
2023
Q1 		$343K Sell
417
-197
-32% -$149K 0.89% 10
2022
Q4 		$443K Sell
614
-101
-14% -$74.5K 0.67% 39
2022
Q3 		$493K Sell
715
-207
-22% -$130K 0.62% 45
2022
Q2 		$545K Buy
922
+47
+5% +$30.6K 0.37% 144
2022
Q1 		$611K Buy
875
+256
+41% +$162K 0.23% 194
2021
Q4 		$391K Sell
619
-488
-44% -$300K 0.13% 246
2021
Q3 		$670K Sell
1,107
-698
-39% -$433K 0.22% 202
2021
Q2 		$1.01M Sell
1,805
-866
-32% -$439K 0.29% 180
2021
Q1 		$1.26M Buy
2,671
+265
+11% +$129K 0.35% 173
2020
Q4 		$1.16M Buy
2,406
+1,325
+123% +$715K 0.35% 178
2020
Q3 		$605K Buy
+1,081
New +$655K 0.25% 176

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fort LP's REGN Position: Q3 2024 in Review

Fort LP reduced its Regeneron Pharmaceuticals (REGN) stake by 11% in Q3 2024, selling an estimated $34.5K and leaving 257 shares worth $270K. The position accounts for 0.68% of the portfolio, ranked #61.

Fort LP first reported a position in REGN in Q3 2020 and has held it in 17 quarters since. The position peaked at $1.26M in Q1 2021. 1,391 funds tracked by Wall St. Rank hold REGN as of Q3 2024.

  • Fort LP held 257 shares of Regeneron Pharmaceuticals worth $270K as of Q3 2024.
  • Fort LP sold 31 Regeneron Pharmaceuticals shares in Q3 2024, an estimated $34.5K.
  • Regeneron Pharmaceuticals made up 0.68% of Fort LP's portfolio in Q3 2024, its #61 holding.
  • Fort LP first reported a position in Regeneron Pharmaceuticals in Q3 2020 and has held it in 17 quarters since.
  • Fort LP's Regeneron Pharmaceuticals position peaked at $1.26M in Q1 2021.
  • 1,391 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2024.

Based on Fort LP's 13F filing for Q3 2024, filed 29 Oct 2024.